APG Asset Management N.V. Has $13.36 Million Stock Holdings in The Clorox Company $CLX

Key Points

• APG Asset Management N.V. reduced its stake in The Clorox Company by 5.3%, owning 98,000 shares worth $13.36 million after selling 5,500 shares.
• Clorox reported a quarterly earnings per share (EPS) of $2.87, surpassing analysts' estimates and achieving a revenue of $1.99 billion, marking a 4.5% year-over-year increase.
• Clorox is increasing its quarterly dividend from $1.22 to $1.24, reflecting a 4.2% annual yield, with a payout ratio of 76.07%.

APG Asset Management N.V. cut its holdings in shares of The Clorox Company (NYSE:CLX - Free Report) by 5.3% during the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 98,000 shares of the company's stock after selling 5,500 shares during the quarter. APG Asset Management N.V. owned approximately 0.08% of Clorox worth $13,359,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Wood Tarver Financial Group LLC purchased a new stake in Clorox during the 4th quarter worth approximately $31,000. GW&K Investment Management LLC increased its holdings in shares of Clorox by 239.1% in the 1st quarter. GW&K Investment Management LLC now owns 295 shares of the company's stock valued at $43,000 after acquiring an additional 208 shares during the last quarter. Roble Belko & Company Inc increased its holdings in shares of Clorox by 140.7% in the 1st quarter. Roble Belko & Company Inc now owns 361 shares of the company's stock valued at $53,000 after acquiring an additional 211 shares during the last quarter. IMA Advisory Services Inc. bought a new stake in shares of Clorox in the 1st quarter valued at approximately $58,000. Finally, Menard Financial Group LLC bought a new stake in shares of Clorox in the 4th quarter valued at approximately $63,000. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research analysts recently commented on the company. Citigroup restated a "neutral" rating and set a $135.00 price objective (down from $140.00) on shares of Clorox in a research note on Tuesday, July 15th. Evercore ISI set a $140.00 price objective on Clorox and gave the stock an "underperform" rating in a research note on Tuesday, May 6th. Jefferies Financial Group lowered their price objective on Clorox from $167.00 to $145.00 and set a "buy" rating for the company in a research note on Thursday, June 26th. Wells Fargo & Company upped their price objective on Clorox from $135.00 to $138.00 and gave the stock an "equal weight" rating in a research note on Friday, August 1st. Finally, JPMorgan Chase & Co. lowered their price objective on Clorox from $144.00 to $140.00 and set a "neutral" rating for the company in a research note on Friday, July 25th. One research analyst has rated the stock with a Buy rating, eight have assigned a Hold rating and three have assigned a Sell rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Reduce" and an average price target of $143.36.

Clorox Price Performance

Shares of Clorox stock traded up $0.27 during trading on Friday, hitting $118.21. The stock had a trading volume of 1,815,992 shares, compared to its average volume of 1,647,494. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57. The firm has a market cap of $14.46 billion, a P/E ratio of 18.13, a PEG ratio of 0.95 and a beta of 0.49. The business has a fifty day moving average of $123.98 and a two-hundred day moving average of $134.58. The Clorox Company has a fifty-two week low of $116.53 and a fifty-two week high of $171.37.

Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The company reported $2.87 earnings per share for the quarter, beating the consensus estimate of $2.24 by $0.63. The business had revenue of $1.99 billion during the quarter, compared to analyst estimates of $1.94 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The company's revenue was up 4.5% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.82 earnings per share. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. On average, sell-side analysts expect that The Clorox Company will post 7.15 earnings per share for the current fiscal year.

Clorox Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, August 29th. Stockholders of record on Wednesday, August 13th will be issued a $1.24 dividend. This represents a $4.96 annualized dividend and a dividend yield of 4.2%. This is a positive change from Clorox's previous quarterly dividend of $1.22. The ex-dividend date is Wednesday, August 13th. Clorox's payout ratio is currently 76.07%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.